C12Y 204/0108
Ceramide glucosyltransferase
Official title: Ceramide glucosyltransferase (2.4.1.80)
C12Y204/0108 (Ceramide glucosyltransferase) appears on 4 US grants and 10 published applications in this corpus.
Search patents in C12Y- Granted patents
- 4
- Published applications
- 10
- Assignees
- 11
- Inventors
- 44
- Latest grant
- 26 Oct 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 1 | 0 |
| 2007 | 1 | 1 |
| 2008 | 0 | 1 |
| 2009 | 1 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Method for producing sphingoid base or sphingolipid26 Oct 2021US 11,155,841 B2Ajinomoto Co., Inc.
- Transformed cell harboring DNA or RNA encoding sugar chain synthesizing agent having β1,3-N-acetylglucosaminyltransferase activity8 Dec 2009US 7,629,150 B2Kyowa Hakko Kirin Co., Ltd.
- Process for producing sugar chains using β1,3-N-acetylglucosaminyltransferase9 Oct 2007US 7,279,310 B2Kyowa Hakko Kogyo Co., Ltd.
- Methods for screening therapeutically effective agents3 Jan 2006US 6,982,142 B2John Wayne Cancer Institute
- Cell-free production of carminic acid17 Apr 2025US 2025/0122543 A1Debut Biotechnology, Inc.
- Use of glucosylceramide synthase gene-deficient t cell and therapeutic utilization thereof16 Dec 2021US 2021/0386783 A1School Corporation, Azabu Veterinary Medicine Educational Institution
- Method for producing sphingoid base or sphingolipid28 Jun 2018US 2018/0179563 A1Ajinomoto Co., Inc.
- Method for preparing recombinant glycoprotein having high sialic acid content, through glycosphingolipid synthesis cycle control11 May 2017US 2017/0129932 A1Korea Advanced Institute of Science and Technology
- Salt tolerance sygt gene derived from synechocystis, and uses thereof24 Oct 2013US 2013/0283484 A1Korea Research Institute of Bioscience and Biotechnology
Most cited
By later US patents
- Process for producing sugar chains using β1,3-N-acetylglucosaminyltransferase13US 7,279,310 B2Kyowa Hakko Kogyo Co., Ltd. · 2007
- Transformed cell harboring DNA or RNA encoding sugar chain synthesizing agent having β1,3-N-acetylglucosaminyltransferase activity12US 7,629,150 B2Kyowa Hakko Kirin Co., Ltd. · 2009
- Methods for screening therapeutically effective agents1US 6,982,142 B2John Wayne Cancer Institute · 2006